Position in OGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$406,023
+$192,438 QoQ
Shares Held
29,987
+230.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#200
of 626 holders
Holding Since
Jun 2022
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTECH INVESTMENT MANAGEMENT LLC holds $283,727,682 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
87,915 | $105,447,897 | |
| 2 | JNJ |
Johnson & Johnson
|
292,522 | $74,291,811 | |
| 3 | AZN |
Astrazeneca PLC
|
117,825 | $22,341,975 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
305,070 | $17,578,132 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,233 | $17,085,336 | |
| 6 | MRK |
Merck & Co., Inc.
|
126,723 | $16,283,905 | |
| 7 | ABBV |
AbbVie Inc.
|
46,148 | $11,612,682 | |
| 8 | AMGN |
Amgen Inc
|
31,159 | $11,283,297 |
All Filings in OGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $406,023 | 29,987 | Shares | Sole | 2026-08-10 | |
| 2023-03-31 | $213,585 | 9,081 | Shares | Sole | 2024-10-18 | |
| 2022-12-31 | $2,734,989 | 97,923 | Shares | Sole | 2024-10-18 | |
| 2022-06-30 | $3,409,593 | 101,025 | Shares | Defined | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||